PK-Directed Intravenous Busulfan in Combination with High-Dose Melphalan and Bortezomib As Conditioning Regimen for Patients with Multiple Myeloma

被引:1
作者
Barta, Stefan Klaus [1 ]
Mazumder, Amitabha [2 ]
Carter, Jason [1 ]
Almanzar, Lawrence [1 ]
Elkind, Richard [1 ]
Battini, Ramakrishna [1 ]
Derman, Olga [1 ]
Kornblum, Noah [1 ]
Xue, Xionan [3 ]
Verma, Amit [1 ]
Braunschweig, Ira [1 ]
机构
[1] Montefiore Med Ctr, Bronx, NY 10467 USA
[2] NYU Canc Ctr, New York, NY USA
[3] Albert Einstein Canc Ctr, Bronx, NY USA
关键词
D O I
10.1016/j.bbmt.2013.12.146
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
126
引用
收藏
页码:S104 / S105
页数:2
相关论文
共 50 条
[41]   Bortezomib, Dexamethasone, and High-Dose Melphalan as Conditioning for Stem Cell Transplantation in Young Japanese Multiple Myeloma Patients: A Pilot Study [J].
Naoki Takezako ;
Naohiro Sekiguchi ;
Akihisa Nagata ;
Chiho Homma ;
Satoshi Noto ;
Akiyoshi Miwa .
Indian Journal of Hematology and Blood Transfusion, 2013, 29 :147-151
[42]   Bortezomib, Dexamethasone, and High-Dose Melphalan as Conditioning for Stem Cell Transplantation in Young Japanese Multiple Myeloma Patients: A Pilot Study [J].
Takezako, Naoki ;
Sekiguchi, Naohiro ;
Nagata, Akihisa ;
Homma, Chiho ;
Noto, Satoshi ;
Miwa, Akiyoshi .
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2013, 29 (03) :147-151
[43]   Outpatient high-dose melphalan in multiple myeloma patients [J].
Kassar, Mohamad ;
Medoff, Erin ;
Seropian, Stuart ;
Cooper, Dennis L. .
TRANSFUSION, 2007, 47 (01) :115-119
[44]   High Dose Intravenous Busulfan (BU) and Melphalan (MEL) Followed by Bortezomib (BTZ) as Conditioning with Autologous Peripheral Blood Stem Cell Transplantation (ASCT) for Patients with Multiple Myeloma (MM) [J].
Rodriguez, Tulio E. ;
Stiff, Patrick J. ;
Smith, Scott E. ;
Kaufman, Jonathan L. ;
Lee, Mary ;
Parthasarathy, Mala ;
Earley, Zachary M. ;
Lonial, Sagar ;
Vesole, David H. .
BLOOD, 2010, 116 (21) :582-582
[45]   Busulfan plus melphalan versus high-dose melphalan as conditioning regimens in autologous stem cell transplantation for newly diagnosed multiple myeloma [J].
Byun, Ja Min ;
Lee, Jayoun ;
Shin, Sang-Jin ;
Kang, Minjoo ;
Yoon, Sung-Soo ;
Koh, Youngil .
BLOOD RESEARCH, 2018, 53 (02) :105-109
[46]   High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma [J].
M Cavo ;
G Bandini ;
M Benni ;
A Gozzetti ;
S Ronconi ;
G Rosti ;
E Zamagni ;
RM Lemoli ;
A Bonini ;
A Belardinelli ;
MR Motta ;
S Rizzi ;
S Tura .
Bone Marrow Transplantation, 1998, 22 :27-32
[47]   High-dose melphalan followed by two doses of bortezomib as conditioning regimen for the patients with multiple myeloma may increase response rate after autologous stem cell transplantation [J].
Liu, K-Y. ;
Chen, H. ;
Jiang, B. ;
Wang, Y. ;
Zhu, H. -H. ;
Sun, Y. -Q. ;
Lu, J. ;
Bao, L. ;
Huang, X. -J. .
BONE MARROW TRANSPLANTATION, 2012, 47 :S188-S188
[48]   High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma [J].
Cavo, M ;
Bandini, G ;
Benni, M ;
Gozzetti, A ;
Ronconi, S ;
Rosti, G ;
Zamagni, E ;
Lemoli, RM ;
Bonini, A ;
Belardinelli, A ;
Motta, MR ;
Rizzi, S ;
Tura, S .
BONE MARROW TRANSPLANTATION, 1998, 22 (01) :27-32
[49]   A Phase 1 Study of Intravenous Busulfan as a Conditioning Regimen for Multiple Myeloma [J].
Radhakrishnan, Sabarinath, V ;
Boyer, Michael ;
Sherwin, Catherine M. ;
Zangari, Maurizio ;
Tricot, Guido .
CELL TRANSPLANTATION, 2019, 28 (12) :1624-1631
[50]   A phase I/II study of escalating doses of thalidomide in conjunction with bortezomib and high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma [J].
Biran, Noa ;
Rowley, Scott D. ;
Vesole, David H. ;
Zhang, Shijia ;
Donato, Michele L. ;
Skarbnik, Alan P. ;
Richter, Joshua ;
Pecora, Andrew ;
Siegel, David S. .
BONE MARROW TRANSPLANTATION, 2019, 54 (11) :1881-1891